Joseph Feingold

A neuroscientist turned biotech strategy expert with deep experience navigating complex challenges in global markets, Joseph combines scientific and entrepreneurial skillsets to perform rigorous analysis and deliver critical insights to biopharma, diagnostics, and medical device leaders.

Joseph supports a range of clients across therapeutic areas and modalities, with particular focus on hematology / oncology, neurology, and rare diseases, developing strategies for pipeline products and portfolios to guide BD, clinical development, and commercialization. An expert on novel technologies, Joseph heads Putnam’s center of excellence on advanced technologies, including cell and gene therapies, requiring sophisticated hospital-based administration and development of new commercialization models.

Joseph earned a PhD in Biomedical Engineering from Harvard-MIT, where he specialized in neurophysiology. He also earned a Masters in Mathematics from Cambridge University and graduated magna cum laude from Harvard University with a degree in Physics and Philosophy.